Report overview
The global Single Gene Genetic Disease Screening Services market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Pre-Pregnancy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Single Gene Genetic Disease Screening Services include Yikon, BGI, DiagCor Bioscience, CapitalBio Technology, ANNOROAD, Berry Genomics, Chengdu 23Mofang Biotechnology, WeGene and Peking Jabrehoo Med Tech, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Single gene genetic disease screening service is a medical service that identifies individuals who carry genetic mutations associated with specific genetic diseases caused by a single gene. The screening process typically involves a blood test or saliva sample analysis to determine whether a person has a genetic mutation that can cause a particular single-gene disorder, such as cystic fibrosis, sickle cell anemia, or Huntington's disease.
The purpose of this screening service is to identify individuals who may be carriers of these genetic mutations and who could pass them on to their children. It allows couples to make informed decisions about their reproductive options, such as undergoing pre-implantation genetic diagnosis (PGD), prenatal testing, or considering adoption. This screening service can also be used for individuals who have a family history of a specific genetic disease to determine whether they are at risk of developing the disease themselves or passing it on to their children.
This report aims to provide a comprehensive presentation of the global market for Single Gene Genetic Disease Screening Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Gene Genetic Disease Screening Services. This report contains market size and forecasts of Single Gene Genetic Disease Screening Services in global, including the following market information:
Global Single Gene Genetic Disease Screening Services Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Single Gene Genetic Disease Screening Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single Gene Genetic Disease Screening Services Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Single Gene Genetic Disease Screening Services Market Segment Percentages, by Type, 2023 (%)
Pre-Pregnancy
Early Pregnancy
Others
Global Single Gene Genetic Disease Screening Services Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Single Gene Genetic Disease Screening Services Market Segment Percentages, by Application, 2023 (%)
Assisted Reproduction
Scientific Research
Others
Global Single Gene Genetic Disease Screening Services Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Single Gene Genetic Disease Screening Services Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Single Gene Genetic Disease Screening Services revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Single Gene Genetic Disease Screening Services revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Yikon
BGI
DiagCor Bioscience
CapitalBio Technology
ANNOROAD
Berry Genomics
Chengdu 23Mofang Biotechnology
WeGene
Peking Jabrehoo Med Tech
AIERKANG
YUNKANG
BOKE bioscience
Guangzhou Darui Biotechnology
Shanghai Find Biotechnology
USCI
Outline of Major Chapters:
Chapter 1: Introduces the definition of Single Gene Genetic Disease Screening Services, market overview.
Chapter 2: Global Single Gene Genetic Disease Screening Services market size in revenue.
Chapter 3: Detailed analysis of Single Gene Genetic Disease Screening Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Single Gene Genetic Disease Screening Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
